Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Gastrointestinal Cancers
•
Gastroesophageal Cancer
How would you treat a patient with adenocarcinoma of the GE junction in the setting of interstitial lung disease?
Is neoadjuvant chemoradiation or perioperative chemotherapy preferred?
Answer from: Radiation Oncologist at Academic Institution
Protons.
Sign in or Register to read more
6623
Related Questions
How likely is late radiation induced lumbosacral plexopathy from treatment of anal cancer with chemo-RT 20 years ago and how would you manage it?
What treatments, after appropriate dose reductions/delays, do you offer for patients with oxaliplatin-induced cold allodynia/dysesthesia?
What are your top takeaways from ASCO GI 2025?
Are you incorporating TTFields into treatment protocols for locally advanced pancreatic cancer based on the PANOVA-3 study?
In a patient with esophageal cancer with lymph node involvement, would you consider treating with definitive chemo-radiation if they have a single area of retroperitoneal metastasis?
Is it safe to treat the stomach to a definitive dose if the patient has a G-tube/PEG in place?
Would you recommend radiation or chemoradiation in a patient with cholangiocarcinoma s/p surgery and adjuvant treatment with single hepatic metastasis 3 years later?
How would you plan adjuvant radiation for an incidental gallbladder carcinoma after cholecystectomy, pT2 with negative margins, now s/p partial hepatectomy and lymphadenectomy with positive nodal disease in a patient who could not tolerate systemic therapy?
Would you hold HAI/ FUDR for SBRT of a residual liver metastasis following hepatic metastasectomy?
Would you change treatment approach for rectal cancer with an associated intussusception?